Fresh from the Newsstand, the “Acta Ophthalmologica” app keeps you up to date with all the latest research within ophthalmology
Acta Ophthalmologica
What is it about?
Fresh from the Newsstand, the “Acta Ophthalmologica” app keeps you up to date with all the latest research within ophthalmology. Acta Ophthalmologica issues can be read in full, giving you all the latest news and research in the field, with podcasts and videos giving additional expert insight and opinion.
App Screenshots
App Store Description
Fresh from the Newsstand, the “Acta Ophthalmologica” app keeps you up to date with all the latest research within ophthalmology. Acta Ophthalmologica issues can be read in full, giving you all the latest news and research in the field, with podcasts and videos giving additional expert insight and opinion.
Download the app today to enjoy a new reading experience. Main features include:
• Download and read Acta Ophthalmologica’s most recent issues
• Stay current with the latest articles published
• Be notified when a new issue is available
• Save your favorite articles for quick and easy access offline
• Browse, search and bookmark articles from all available issues
• Browse and zoom in on images
• Share links to your favorite articles with colleagues and friends
CURRENT SUBSCRIBERS to Acta Ophthalmologica can “pair” their device with their personal or institutional subscription to enjoy full access in this iPad edition.
SUBSCRIBE IN THE APP: Annual Subscriptions (8 issues) for the iPad-only edition are available for $249.99 (US) per year. Payment is charged to your iTunes account after confirmation of purchase. Acta Ophthalmologica subscriptions automatically renew within 24 hours of the end of your subscription period for $249.99 (US) unless auto-renew is turned off at least 24 hours before the end of the subscription period. To turn off auto-renew, go to your iTunes account settings after purchase. Note that subscriptions cannot be cancelled during the term of the subscription, but you can still turn off auto-renew to prevent automatic renewal of your subscription. Note that any unused portion of a free trial period, if offered, will be forfeited when you purchases a subscription.
Acta Ophthalmologica is the official scientific publication of the five Nordic ophthalmological societies: The Danish Ophthalmological Society, The Finnish Ophthalmological Society, The Icelandic Ophthalmological Society, The Norwegian Ophthalmological Society and The Swedish Ophthalmological Society, and also the European Association for Vision and Eye Research (EVER).
Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor and doctoral theses.
CURRENT SUBSCRIBERS to Acta Ophthalmologica can “pair” their device with their personal or institutional subscription to enjoy full access in this iPad edition.
SUBSCRIBE IN THE APP: Annual Subscriptions (12 issues) for the iPad-only edition are available for $249.99 (US) per year. Payment is charged to your iTunes account after confirmation of purchase. Acta Ophthalmologica subscriptions automatically renew within 24 hours of the end of your subscription period for $249.99 (US) unless auto-renew is turned off at least 24 hours before the end of the subscription period. To turn off auto-renew, go to your iTunes account settings after purchase. Note that subscriptions cannot be cancelled during the term of the subscription, but you can still turn off auto-renew to prevent automatic renewal of your subscription. Note that any unused portion of a free trial period, if offered, will be forfeited when you purchases a subscription.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.